New Student Offer - Use Code HELLO

Register Now

‘Ivejaj’ Tablets for COVID-19 Treatment

Published on May 07, 2021
Current Context: Bajaj Healthcare Limited has announced the launch of ‘Ivejaj’ (Ivermectin) which is an Anti-Parasitic Drug used in control & offers treatment for Covid-19 patients.
‘Ivejaj’ Tablets for COVID-19 Treatment
  • The company has also received approval from India's drug regulator, DCGI to manufacture and market ‘Ivejaj’.
  • Bajaj Healthcare Limited has developed the active pharmaceutical ingredient and the formulation for Ivermectin through its R&D team.

Question: 

Q.1 Which organisation developed ‘Ivejaj’ (Ivermectin) which is an Anti-Parasitic Drug used in control & offers treatment for Covid-19 patients?
a. Syncom Healthcare
b. Eris Lifesciences
c. Bajaj Healthcare Limited
d. Parabolic Drugs Ltd.
ebook store

About us

ramandeep singh

Ramandeep Singh, your guide to banking and insurance exams. With 14 years of experience and 5000+ selections, Ramandeep understands the path to success, having transitioned himself from Dena Bank and SBI. He's passionate about helping you achieve your banking and insurance dreams.

  • Follow me:
Close Menu
Close Menu